Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
NCT Number: NCT01650974
The purpose of this study is to determine the efficacy and safety of nasal high flow oxygen therapy during diagnostic bronchoscopy.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Hypoxemia is frequently seen during diagnostic bronchoscopy. Nasal prong or other existing oxygen supply methods are often difficult to maintain adequate oxygenation during bronchoscopy. In particular, bronchoscopy to patients already showing hypoxemia can be dangerous even though applying conventional oxygen therapy. Thus, we want to elucidate the usefulness of nasal high flow oxygen therapy to hypoxemic patients undergoing diagnostic bronchoscopy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1 or 2
Exclusion criteria
high flow nasal oxygen therapy
Other names: high flow nasal oxygen therapy(OPTIFLOW)
Time frame: 1 day
Success is defined as completion of planned diagnostic procedure with the oxygen saturation or partial pressure of oxygen in arterial blood was similar to the level of before the procedure.
Failure is defined as incompletion of planned diagnostic procedure due to sustained hypoxemia or else.
Furthermore failure is defined as hypoxemia(SaO2 <88%) was developed more than 2 times even though planned procedure was completed.
Time frame: 1 day
total duration of hypoxia(oxygen saturation ≤88%) during procedure or after procedure.
Time frame: 1 day
frequency of hypoxia(oxygen saturation ≤88%) during procedure or after procedure.
Time frame: 1 day
Increase oxygen apply or change of oxygen therapy method to high flow system.
Time frame: 1 day
scoring of dyspnea symptoms, patients comfort.
Seoul National University Hospital
Other
High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy: A Prospective, Randomized, Controlled Study
Acronym: HFNOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720960
Erythropoiesis, Hypoxia
Elche, Alicante, Spain
View Trial DetailsNCT05767385
Cardiovascular Abnormalities, Cardiovascular Diseases
San Francisco, California, United States
View Trial DetailsNCT01542177
Digestive System Diseases, Digestive System Neoplasms
Toronto, Ontario, Canada
View Trial DetailsNCT05354648
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details